Total Payments
$670,672
2024 Payments
$20,064
Companies
52
Transactions
1,187
Medicare Patients
7,530
Medicare Billing
$782,129
Payment Breakdown by Category
Other$486,247 (72.5%)
Consulting$80,031 (11.9%)
Travel$78,684 (11.7%)
Food & Beverage$25,195 (3.8%)
Education$515.42 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $484,334 | 227 | 72.2% |
| Consulting Fee | $80,031 | 33 | 11.9% |
| Travel and Lodging | $78,684 | 235 | 11.7% |
| Food and Beverage | $25,195 | 673 | 3.8% |
| Honoraria | $1,913 | 1 | 0.3% |
| Education | $515.42 | 18 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $317,618 | 380 | $0 (2024) |
| GlaxoSmithKline, LLC. | $118,113 | 169 | $0 (2024) |
| Mylan Specialty L.P. | $96,613 | 147 | $0 (2022) |
| Genentech USA, Inc. | $51,082 | 65 | $0 (2021) |
| Insmed, Inc. | $38,168 | 67 | $0 (2023) |
| Mylan Inc. | $18,892 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $9,258 | 92 | $0 (2024) |
| Grifols USA, LLC | $5,065 | 12 | $0 (2024) |
| Circassia Pharmaceuticals Inc | $3,159 | 16 | $0 (2019) |
| ANI Pharmaceuticals, Inc. | $2,005 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,064 | 29 | Mylan Inc. ($17,302) |
| 2023 | $17,080 | 53 | GlaxoSmithKline, LLC. ($14,130) |
| 2022 | $41,185 | 64 | GlaxoSmithKline, LLC. ($36,442) |
| 2021 | $57,680 | 73 | GlaxoSmithKline, LLC. ($21,908) |
| 2020 | $116,376 | 146 | Mylan Specialty L.P. ($34,348) |
| 2019 | $210,662 | 347 | Boehringer Ingelheim Pharmaceuticals, Inc. ($98,919) |
| 2018 | $108,805 | 237 | Boehringer Ingelheim Pharmaceuticals, Inc. ($103,365) |
| 2017 | $98,820 | 238 | Boehringer Ingelheim Pharmaceuticals, Inc. ($89,336) |
All Payment Transactions
1,187 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $108.66 | General |
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/22/2024 | Mylan Inc. | YUPELRI (Drug) | Consulting Fee | Cash or cash equivalent | $6,190.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/22/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Inflammation | ||||||
| 07/16/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Education | Cash or cash equivalent | $84.99 | General |
| Category: Narcoplepsy | ||||||
| 07/16/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $21.80 | General |
| Category: Narcoplepsy | ||||||
| 07/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: RESPIRATORY | ||||||
| 06/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Immunology | ||||||
| 06/13/2024 | Mylan Inc. | YUPELRI (Drug) | Travel and Lodging | In-kind items and services | $134.03 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/12/2024 | Mylan Inc. | YUPELRI (Drug) | Travel and Lodging | In-kind items and services | $4,769.40 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/07/2024 | Mylan Inc. | YUPELRI (Drug) | Travel and Lodging | In-kind items and services | $209.83 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/06/2024 | Mylan Inc. | YUPELRI (Drug) | Travel and Lodging | In-kind items and services | $294.80 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/05/2024 | Mylan Inc. | — | Travel and Lodging | In-kind items and services | $134.03 | General |
| 06/04/2024 | Mylan Inc. | YUPELRI (Drug) | Travel and Lodging | In-kind items and services | $710.21 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/04/2024 | Mylan Inc. | YUPELRI (Drug) | Travel and Lodging | In-kind items and services | $134.03 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/03/2024 | Mylan Inc. | YUPELRI (Drug) | Travel and Lodging | In-kind items and services | $4,725.80 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $123.77 | General |
| Category: Respiratory | ||||||
| 04/23/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Cardiology | ||||||
| 04/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: RESPIRATORY | ||||||
| 03/25/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $58.66 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 03/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: VACCINES | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Respiratory | ||||||
| 03/12/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $31.90 | General |
| Category: Pulmonology | ||||||
| 02/23/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 02/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,014 | 3,637 | $598,694 | $193,882 |
| 2022 | 17 | 1,928 | 2,404 | $589,791 | $200,742 |
| 2021 | 20 | 1,800 | 2,268 | $465,419 | $191,039 |
| 2020 | 19 | 1,788 | 2,258 | $500,857 | $196,466 |
Total Patients
7,530
Total Services
10,567
Medicare Billing
$782,129
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 718 | 1,101 | $280,755 | $93,155 | 33.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 38 | 41 | $38,829 | $21,874 | 56.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 129 | 129 | $37,152 | $14,118 | 38.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 98 | 100 | $35,000 | $8,961 | 25.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 33 | 56 | $33,880 | $8,550 | 25.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 88 | 89 | $28,925 | $8,023 | 27.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 148 | 149 | $17,880 | $5,777 | 32.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 70 | 70 | $33,218 | $5,292 | 15.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 56 | $10,304 | $4,703 | 45.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 151 | 152 | $15,200 | $4,516 | 29.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $10,440 | $3,817 | 36.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 112 | 114 | $11,742 | $3,008 | 25.6% |
| 94660 | Therapy procedure using a positive pressure ventilator | Facility | 2023 | 87 | 88 | $21,120 | $2,368 | 11.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 26 | 26 | $2,210 | $1,798 | 81.4% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2023 | 32 | 32 | $2,679 | $1,712 | 63.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 26 | $4,498 | $1,302 | 28.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 41 | 41 | $1,255 | $1,166 | 92.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 63 | 63 | $3,717 | $1,086 | 29.2% |
| J7674 | Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg | Office | 2023 | 14 | 1,202 | $4,808 | $741.18 | 15.4% |
| 94070 | Test to measure lung airway sensitivity | Office | 2023 | 14 | 14 | $1,918 | $593.71 | 31.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $585.00 | $483.48 | 82.6% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 14 | 14 | $938.00 | $369.20 | 39.4% |
| 95070 | Test for allergy using drugs | Office | 2023 | 14 | 14 | $1,316 | $322.79 | 24.5% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 13 | 13 | $325.00 | $144.28 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 706 | 1,036 | $257,505 | $89,537 | 34.8% |
About Dr. Aaron Milstone, MD
Dr. Aaron Milstone, MD is a Pulmonary Disease healthcare provider based in Franklin, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134211550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Milstone, MD has received a total of $670,672 in payments from pharmaceutical and medical device companies, with $20,064 received in 2024. These payments were reported across 1,187 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($484,334).
As a Medicare-enrolled provider, Milstone has provided services to 7,530 Medicare beneficiaries, totaling 10,567 services with total Medicare billing of $782,129. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine, Critical Care Medicine
- Location Franklin, TN
- Active Since 09/30/2006
- Last Updated 09/05/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1134211550
Products in Payments
- OFEV (Drug) $136,596
- Yupelri (Drug) $81,841
- TRELEGY ELLIPTA (Drug) $54,753
- Xofluza (Drug) $50,855
- YUPELRI (Drug) $29,522
- Arikayce (Drug) $27,508
- STIOLTO RESPIMAT (Drug) $10,202
- ANORO ELLIPTA (Drug) $7,586
- Prolastin-C Liquid (Biological) $3,611
- DUAKLIR (Drug) $3,007
- SPIRIVA (Drug) $2,050
- PURIFIED CORTROPHIN GEL (Drug) $2,005
- XOLAIR (Biological) $1,865
- Prolastin-C (Biological) $1,455
- BREZTRI (Drug) $1,012
- BREZTRI AEROSPHERE (Drug) $393.39
- STIOLTO (Drug) $349.63
- FASENRA (Biological) $329.63
- OPSUMIT MACITENTAN (Drug) $228.29
- SYMBICORT (Drug) $222.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Franklin
David Kristo, M.d, M.D
Pulmonary Disease — Payments: $13,914
Pulmonary Disease $13,914
Laura Hunt, Md, MD
Pulmonary Disease — Payments: $6,383
Pulmonary Disease $6,383
Isam Habib, Md, MD
Pulmonary Disease — Payments: $4,488
Pulmonary Disease $4,488
Dr. Pravin Patel, Md, MD
Pulmonary Disease — Payments: $30.11
Pulmonary Disease $30.11
Amgad Abdu
Pulmonary Disease — Payments: $29.20
Pulmonary Disease $29.20
Dr. Luis Portilla, M.d, M.D
Pulmonary Disease — Payments: $4.32
Pulmonary Disease $4.32